bismuth has been researched along with B-Cell Lymphoma in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Robotis, J; Rokkas, T; Tsiodras, S | 1 |
| Friesen, C; Hormann, I; Leib, O; Marx, S; Miltner, E; Moreno, J; Roscher, M | 1 |
| Brechbiel, MW; Goldenberg, DM; Jackson, TJ; Mattes, MJ; Michel, RB; Rosario, AV | 1 |
| Apostolidis, C; Bacher, K; de Gelder, V; De Vos, F; Dierckx, R; Janssens, A; Morgenstern, A; Offner, F; Philippé, J; Slegers, G; Thierens, H; Vandenbulcke, K | 1 |
4 other study(ies) available for bismuth and B-Cell Lymphoma
| Article | Year |
|---|---|
Helicobacter pylori eradication may successfully treat primary cutaneous follicle center lymphoma.
Topics: Amoxicillin; Anti-Bacterial Agents; Bismuth; Clarithromycin; Doxycycline; Female; Helicobacter Infections; Helicobacter pylori; Humans; Lansoprazole; Lymphoma, B-Cell; Metronidazole; Middle Aged; Organometallic Compounds; Rabeprazole; Salicylates | 2018 |
Anti-CD33-antibodies labelled with the alpha-emitter Bismuth-213 kill CD33-positive acute myeloid leukaemia cells specifically by activation of caspases and break radio- and chemoresistance by inhibition of the anti-apoptotic proteins X-linked inhibitor o
Topics: Antibodies, Monoclonal; Apoptosis; bcl-X Protein; Bismuth; Caspases; Cell Line, Tumor; Drug Resistance, Neoplasm; HL-60 Cells; Humans; Immunoconjugates; Leukemia, Myeloid, Acute; Lymphoma, B-Cell; Radioimmunotherapy; Radioisotopes; Sialic Acid Binding Ig-like Lectin 3; X-Linked Inhibitor of Apoptosis Protein | 2013 |
Experimental therapy of disseminated B-Cell lymphoma xenografts with 213Bi-labeled anti-CD74.
Topics: Animals; Antibodies; Antigens, Differentiation, B-Lymphocyte; Bismuth; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Radiation; Histocompatibility Antigens Class II; Lymphoma, B-Cell; Mice; Mice, SCID; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Radiotherapy Dosage; Survival; Tissue Transplantation; Transplantation, Heterologous; Treatment Outcome | 2003 |
Importance of receptor density in alpha radioimmunotherapy in B cell malignancies: an in-vitro study.
Topics: Alpha Particles; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Apoptosis; Bismuth; Humans; Lymphoma, B-Cell; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Receptors, Cytokine; Rituximab; Treatment Outcome; Tumor Cells, Cultured | 2004 |